Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac Surgery

Annals of Thoracic Surgery

Volumn 83, Issue 2, 2007, Pages 592-597

  Everett, Brendan M ^a   Yeh, Robert ^a   Foo, Shi Yin ^a   Criss, David ^a   Van Cott, Elizabeth M ^a   Laposata, Michael ^a   Avery, Edwin G ^a   Hoffman, William D ^a   Walker, Jennifer ^a   Torchiana, David ^a   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; FONDAPARINUX; HEPARIN; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG; WARFARIN;

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POPULATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AGED; ANTIBODIES; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET FACTOR 4; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 33846384287     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.09.040     Document Type: Article

References (17)

1. Jang I.K., and Hursting M.J. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 111 (2005) 2671-2683
2. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131
3. Chong B.H., Fawaz I., Chesterman C.N., and Berndt M.C. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73 (1989) 235-240
4. Warkentin T.E., Hayward C.P., Boshkov L.K., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84 (1994) 3691-3699
5. Warkentin T.E., and Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am J Med 101 (1996) 502-507
6. Arepally G.M., and Mayer I.M. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 98 (2001) 1252-1254
7. Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121 (2003) 535-555
8. Trossaert M., Gaillard A., Commin P.L., Amiral J., Vissac A.M., and Fressinaud E. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 101 (1998) 653-655
9. Warkentin T.E., Sheppard J.A., Horsewood P., Simpson P.J., Moore J.C., and Kelton J.G. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 (2000) 1703-1708
10. Visentin G.P., Malik M., Cyganiak K.A., and Aster R.H. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Med 128 (1996) 376-383
11. Pouplard C., May M.A., Iochmann S., et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 99 (1999) 2530-2536
12. Francis J.L., Palmer III G.J., Moroose R., and Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 75 (2003) 17-22
13. Bauer T.L., Arepally G., Konkle B.A., et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95 (1997) 1242-1246
14. Bennett-Guerrero E., Slaughter T.F., White W.D., et al. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg 130 (2005) 1567-1572
15. Hirsh J., Heddle N., and Kelton J.G. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 164 (2004) 361-369
16. Pouplard C., May M.A., Regina S., et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 128 (2005) 837-841
17. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 311S-337S